Awakura, Y., Ito, N., Nakamura, E., Takahashi, T., Kotani, H., Mikami, Y., Manabe, T., Kamoto, T., Habuchi, T. and Ogawa, O. (2006) Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett., 241, 59-63.
Horie, N.,Murata,H.,Nishigaki,Y.,Matsui,T.,Segawa,H.,Nogawa,M.,Yuasa, T., Kimura, S., Maekawa, T., Fushiki, S. and Kubo, T. (2006) The third-generation bisphosphonates inhibit tumor proliferation and induce apoptosis in murine osteosarcoma in vitro. Cancer Lett., 238, 111-118.
Hoshi, S., Yamaguchi, O., Fujioka, T., Arai, Y., Tomita, Y., Habuchi, T., Ohyama, C., Suzuki, T. and Orikasa S. (2006) A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer. Int. J. Clin. Oncol., 11, 303-308.
Inoue, T., Satoh, S., Numakura, K., Saito, M., Tsuchiya, N., Nanjo, H., Yamamoto, H., Amada, N. and Habuchi, T. (2006) External iliac pseudoaneurysm ruptured into non-functioning intrarenal allograft abscessed mass. Nephrol. Dial. Transplant., 21, 1727-1728.
Inoue, T., Ito, T., Narita, S., Horikawa, Y., Tsuchiya, N., Kakinuma, H., Mishina, M., Nakamura, E., Kato, T., Ogawa, O. and Habuchi, T. (2006) Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients. Cancer Lett., 240, 41-47.
Ishimura, H., Takahashi, T., Nakagawa, H., Nishimura, S., Arai, Y., Horikawa, Y., Habuchi, T., Miyoshi, E., Kyan, A., Hagisawa, S. and Ohyama, C. (2006) N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer. Clin. Cancer Res., 12, 2506-2511.
Ito, M., Nishiyama, H., Watanabe, J., Kawanishi, H., Takahashi, T., Kamoto, T., Habuchi, T. and Ogawa, O. (2006) Association of the PIG3 promoter polymorphism with invasive bladder cancer in a Japanese population. Jpn. J. Clin. Oncol., 36, 116-120.
Kagaya, H., Inoue, K., Miura, M., Satoh, S., Saito, M., Tada, H., Habuchi, T. and Suzuki, T. (2006) Quantification and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients. Yakugaku Zasshi, 126, 1357-1362.
Kataoka, A., Yuasa, T., Kageyama, S., Tsuchiya, N., Habuchi, T., Iwaki, H., Narita, M., Okada, Y. and Yoshiki, T. (2006) Diagnosis of bone metastasis in men with prostate cancer by measurement of serum ICTP in combination with alkali phosphatase and prostate-specific antigen. Clin. Oncol., 18, 480-484.
Kawanishi, H., Takahashi, T., Ito, M., Watanabe, J., Higashi, S., Kamoto ,T., Habuchi, T., Kadowaki, T., Tsujimoto, G., Nishiyama, H. and Ogawa, O. (2006) High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers. Cancer Sci., 97, 746-752.
Kobayashi, T., Kawakita, M., Terachi, T., Habuchi, T., Ogawa, O. and Kamoto, T. (2006) Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors. J. Surg. Oncol., 94, 619-623.
Matsuura, S., Obara, T., Tsuchiya, N., Suzuki, Y. and Habuchi, T. (2006) Cavernous nerve regeneration by biodegradable alginate gel sponge sheet placement without sutures. Urology, 68, 1366-1371.
Miura, M., Satoh, S., Tada, H., Saito, M., Kagaya, H., Inoue, K., Sagae, Y., Kanno, S., Ishikawa, M., Habuchi, T. and Suzuki, T. (2006) Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus. Int. J. Clin. Pharmacol. Ther., 44, 605-613.
Miura, M., Tada, H., Satoh, S., Habuchi, T. and Suzuki, T. (2006) Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction. J. Pharm. Biomed. Anal., 41, 565-570.
Miura, M., Satoh, S., Tada, H., Habuchi, T. and Suzuki, T. (2006) Stereoselective metabolism of rabeprazole-thioether to rabeprazole by human liver microsomes. Eur. J. Clin. Pharmacol., 62, 113-117.
Narita, S., Inoue, T., Matsuura, S., Horikawa, Y., Kakinuma, H., Saito, M., Kumazawa, T., Cavernous nerve regeneration by biodegradable alginate gel sponge sheet, N., Satoh, S. and Habuchi, T. (2006) Outcome of right hand-assisted retroperitoneoscopic living donor nephrectomy. Urology, 67, 496-500; discussion 500-491.
Obara, T., Matsuura, S., Narita, S., Satoh, S., Tsuchiya, N. and Habuchi, T. (2006) Bladder acellular matrix grafting regenerates urinary bladder in the spinal cord injury rat. Urology, 68, 892-897.
Sato, K., Yuasa, T., Nogawa, M., Kimura, S., Segawa, H., Yokota, A., Maekawa, T. (2006) A third generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo. Br. J. Cancer, 95, 1354-1361, 2006.
Satoh, S., Tada, H., Murakami, M., Tsuchiya, N., Li, Z., Numakura, K., Saito, M., Inoue, T., Miura, M., Hayase, Y., Suzuki, T. and Habuchi, T. (2006) Circadian pharmacokinetics of mycophenolic Acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients. Transplantation, 82, 486-493.
Tsuchiya, N., Wang, L., Suzuki, H., Segawa, T., Fukuda, H., Narita, S., Shimbo, M., Kamoto, T., Mitsumori, K., Ichikawa, T., Ogawa, O., Nakamura, A. and Habuchi, T. (2006) Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer. J. Clin. Oncol., 24, 1982-1989.
Tsuchiya, N., Mishina, M., Narita, S., Kumazawa, T., Inoue, T., Horikawa, Y., Kakinuma, H., Yuasa, T., Matsuura, S., Satoh, S., Ogawa, O. and Habuchi, T. (2006) Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors. Int. J. Oncol., 28, 1217-1223.
Tsuchiya, N., Satoh, S., Sato, K., Iinuma, M., Narita, S., Inoue, T., Matsuura, S. and Habuchi, T. (2006) Hand assisted retroperitoneoscopic living donor nephrectomy in elderly donors. J. Urol., 175, 230-234.
Tsuruta, H., Kishimoto, H., Sasaki, T., Horie, Y., Natsui, M., Shibata, Y., Hamada, K., Yajima, N., Kawahara, K., Sasaki, M., Tsuchiya, N., Enomoto, K., Mak, T.W., Nakano, T., Habuchi, T. and Suzuki, A. (2006) Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients. Cancer Res., 66, 8389-8396.
Takahashi, T., Higashi, S., Nishiyama, H., Segawa, T., Nakamura, E., Kinoshita, H., Itoh, N., Yamamoto, S., Kamoto, T., Habuchi, T. and Ogawa, O. (2006) Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen. Jpn. J. Clin. Oncol., 36, 104-108.
Yuasa, T., Tsuchiya, N., Narita, S., Inoue, T., Saito, M., Kumazawa, T., Horikawa, Y., Matsuura, S., Satoh, S., Nanjo, H. and Habuchi, T. (2006) Radical nephroureterectomy as initial treatment for carcinoma in situ of upper urinary tract. Urology, 68, 972-975.
Yuasa, T., Yoshida, T., Wakabayashi, Y., Kataoka, A., Narita, M., Yoshiki, T., Okada, Y. Successful treatment of disseminated extragonadal germ cell cancer with intensive conventional chemotherapy after first-line high dose chemotherapy. (2006) Int. J. Clin. Oncol. 11, 60-63.